To hear about similar clinical trials, please enter your email below
Trial Title:
Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling-Establish Reliably Electrophysiological Readouts From Human-induced Pluripotent Stem Cells (hiPSCs)-Derived Cerebral Organoids and Surgically Dissected Human Live Brains
NCT ID:
NCT05921786
Condition:
Brain Diseases
Brain Tumor
Conditions: Official terms:
Brain Neoplasms
Brain Diseases
Conditions: Keywords:
brain diseases, brain tumor
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Basic Science
Masking:
None (Open Label)
Intervention:
Intervention type:
Device
Intervention name:
Electrophysiological system
Description:
Electrophysiological system is used for examining voltage variation in biological
samples. And multiphoton microscopy is a common type of nonlinear optical microscope.
Arm group label:
Electrophysiological system
Intervention type:
Device
Intervention name:
Multiphoton microscope
Description:
Multiphoton microscope acquires high-resolution image based on nonlinear optics and can
be used for detect biological specimens.
Arm group label:
Multiphoton microscopy
Summary:
The research aims to establish a big database of multiple kinds of brain tissues and
prove the relevance of human brain tissue models and hiPSCs-derived organoid models.
Detailed description:
Brain diseases are very difficult diseases to treat, and when developing related medical
cures for saving lives, however, it is difficult to obtain examining samples, especially
like normal brain tissue since it is necessary to preserve the brain tissue of patients
to ensure its functionality. Among the numerous brain diseases, there are many diseases
that combine surgery, chemotherapy, and immunotherapy in treatment. For example, for
brain tumors, surgery is the most important treatment that can effectively prolong the
survival time of patients. Numerous neurological functions, tumors generated in such
important organs, require careful judgment of resection strategy in surgical treatment.
In addition to achieving complete tumor resection, subsequent chemotherapy and
immunotherapy are also important factors to improve prognosis. Traditionally, the
neurosurgeon's experience and various preoperative examinations are used to judge the
type and distribution of the disease, which may lead to inconsistent results due to
different personal experiences. The current methods that can be used clinically to help
improve the integrity of resection (such as intraoperative fluorochrome and
intraoperative magnetic resonance imaging) are relatively indirect methods of judgment,
but it is hard to directly know the detailed information of the disease before surgery,
and the assessment results of formalin-fixed paraffin-embedded (FFPE) section through the
standard operation of pathological procedures are used to formulate drug treatment
strategies, which may greatly affect the prognosis of patients. According to the current
intraoperative cryopathology, there are many brain tumors that cannot be classified
easily by it. When searching the literature, there are also few related studies that try
to solve this problem, but in addition to the insufficient sample size, it is also
impossible to acquire appropriate conclusions due to the limited number of samples.
Therefore, through this study, we want to implement optical microscopy and
electrophysiological analysis system to capture images and electrophysiological signals
of some remaining brain diseased tissues after surgical resection, and compare the
acquired datas with the results obtained from human brain organoid tissues. Eventually,
construct a large database of brain tissue can also verify whether human brain organoids
can completely compare with real human brain samples can truly improve the medical
operation.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Patients older than the age of 18 with diagnosis of brain disease (both
newly-diagnosed or recurrent) who are suitable and willing to receive resection
surgery.
Exclusion Criteria:
1. Patients who cannot give consent to participate in the study.
2. The tumor samples failed to give a conclusive pathological diagnosis by standard
pathological workflow.
3. Patients who only receives biopsy surgery rather than resection surgery.
4. Significant post-irradiation effect or radiation necrosis reported in the
pathological examination.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University
Address:
City:
Taipei
Country:
Taiwan
Status:
Recruiting
Contact:
Last name:
Kuo-Chuan Wang
Phone:
+886-23123456
Phone ext:
263155
Email:
wang081466@yahoo.com.tw
Start date:
May 1, 2023
Completion date:
December 31, 2026
Lead sponsor:
Agency:
National Taiwan University Hospital
Agency class:
Other
Source:
National Taiwan University Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05921786